Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1

被引:0
|
作者
Y Zhu
D W Hein
机构
[1] University of Louisville School of Medicine,Department of Pharmacology and Toxicology and James Graham Brown Cancer Center
来源
关键词
-acetyltransferase 1; acetylator genotype; acetylator phenotype; single nucleotide polymorphisms (SNPs), functional SNPs, ; -acetylation, ; -acetylation, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine;
D O I
暂无
中图分类号
学科分类号
摘要
Genetic variants of human N-acetyltransferase 1 (NAT1) are associated with cancer and birth defects. N- and O-acetyltransferase catalytic activities, Michaelis–Menten kinetic constants (Km and Vmax) and steady-state expression levels of NAT1-specific mRNA and protein were determined for the reference NAT1*4 and variant human NAT1 haplotypes possessing single nucleotide polymorphisms (SNPs) in the open reading frame. Although none of the SNPs caused a significant effect on steady-state levels of NAT1-specific mRNA, C97T(R33stop), C190T(R64W), C559T (R187stop) and A752T(D251V) each reduced NAT1 protein level and/or N- and O-acetyltransferase catalytic activities to levels below detection. G560A(R187Q) substantially reduced NAT1 protein level and catalytic activities and increased substrate Km. The G445A(V149I), G459A(synonymous) and T640G(S214A) haplotype present in NAT1*11 significantly (P<0.05) increased NAT1 protein level and catalytic activity. Neither T21G(synonymous), T402C(synonymous), A613G(M205V), T777C(synonymous), G781A(E261K) nor A787G(I263V) significantly affected Km, catalytic activity, mRNA or protein level. These results suggest heterogeneity among slow NAT1 acetylator phenotypes.
引用
收藏
页码:339 / 348
页数:9
相关论文
共 50 条
  • [21] Distribution of coding region single nucleotide polymorphisms (SNPs) of human beta defensin 1 (HBD1).
    Taylor, JG
    Leitman, SF
    Chanock, SJ
    BLOOD, 2000, 96 (11) : 611A - +
  • [22] Human serotonin N-acetyltransferase
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (08) : 376 - 376
  • [23] Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2
    Kukongviriyapan, V
    Phromsopha, N
    Tassaneeyakul, W
    Kukongviriyapan, U
    Sripa, B
    Hahnvajanawong, V
    Bhudhisawasdi, V
    XENOBIOTICA, 2006, 36 (01) : 15 - 28
  • [24] Effect of Promoter Region Polymorphisms in N-Acetyltransferase 2 (NAT2) Phenotype
    Yuliwulandari, Rika
    Okamoto, Koji
    Permana, Dharma
    Tokunaga, Katsushi
    DRUG METABOLISM REVIEWS, 2010, 42 : 156 - 157
  • [25] N-Acetyltransferase polymorphisms and colorectal cancer:: A HuGE review
    Brockton, N
    Little, J
    Sharp, L
    Cotton, SC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (09) : 846 - 861
  • [26] N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes
    Cocco, Pierluigi
    Zucca, Mariagrazia
    Sanna, Sonia
    Satta, Giannina
    Nonne, Tinucia
    Angelucci, Emanuele
    Gabbas, Attilio
    Rais, Marco
    Malpeli, Giorgio
    Campagna, Marcello
    Scarpa, Aldo
    Ennas, Maria G.
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (02) : 79 - 83
  • [27] DEVELOPMENT OF HUMAN POLYMORPHIC N-ACETYLTRANSFERASE
    MEISEL, M
    SCHNEIDER, T
    SIEGMUND, W
    NIKSCHICK, S
    KLEBINGAT, KJ
    SCHERBER, A
    BIOLOGICAL RESEARCH IN PREGNANCY AND PERINATOLOGY, 1986, 7 (02): : 74 - 76
  • [28] A microarray system for genotyping 150 single nucleotide polymorphisms in the coding region of human mitochondrial DNA
    Sigurdsson, S
    Hedman, M
    Sistonen, P
    Sajantila, A
    Syvänen, AC
    GENOMICS, 2006, 87 (04) : 534 - 542
  • [29] The expression pattern of N-acetyltransferase 1 in healthy human skin
    van Amerongen, Cynthia C. A.
    Kramer, Duco
    Pas, Hendri H.
    Schuttelaar, Marie L. A.
    CONTACT DERMATITIS, 2021, 85 (01) : 1 - 6
  • [30] Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1
    Barker, David F.
    Husain, Anwar
    Neale, Jason R.
    Martini, Benjamin D.
    Zhang, Xiaoyan
    Doll, Mark A.
    States, J. Christopher
    Hein, David W.
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (07): : 515 - 525